It should be also noted that GLP1-RA therapy has been shown to be favorable in patients surviving a severe acute kidney injury episode, as it has been associated with significantly lower long-term risk of cardiovascular events, kidney disease progression, and overall survival [50]. The gene discussed is GLP1R; the disease is acute kidney injury.